Találati lista | Tudóstér

001-es BibID:	BIBFORM103353
035-os BibID:	(Scopus)85015354198 (WOS)000374833800004
Első szerző:	Kissling, Esther
Cím:	I-MOVE multicentre case-control study 2010/11 to 2014/15 : is there within-season waning of influenza type/subtype vaccine effectiveness with increasing time since vaccination? / E. Kissling, B. Nunes, C. Robertson, M. Valenciano, A. Reuss, A. Larrauri, J. M. Cohen, Beatrix Oroszi, C. Rizzo, A. Machado, D. Pitigoi, L. Domegan, I. Paradowska-Stankiewicz, U. Buchholz, A. Gherasim, I. Daviaud, J. K. Horváth, A. Bella, E. Lupulescu, J. O'Donnell, M. Korczyńska, A. Moren, I-MOVE case-control study team
Dátum:	2016
ISSN:	1560-7917
Megjegyzések:	Since the 2008/9 influenza season, the I-MOVE multicentre case?control study measures influenza vaccine effectiveness (VE) against medically-attended influenza-like-illness (ILI) laboratory confirmed as influenza. In 2011/12, European studies reported a decline in VE against influenza A(H3N2) within the season. Using combined I-MOVE data from 2010/11 to 2014/15 we studied the effects of time since vaccination on influenza type/subtype-specific VE. We modelled influenza type/subtype-specific VE by time since vaccination using a restricted cubic spline, controlling for potential confounders (age, sex, time of onset, chronic conditions). Over 10,000 ILI cases were included in each analysis of influenza A(H3N2), A(H1N1)pdm09 and B; with 4,759, 3,152 and 3,617 influenza positive cases respectively. VE against influenza A(H3N2) reached 50.6% (95% CI: 30.0?65.1) 38 days after vaccination, declined to 0% (95% CI: -18.1?15.2) from 111 days onwards. At day 54 VE against influenza A(H1N1)pdm09 reached 55.3% (95% CI: 37.9?67.9) and remained between this value and 50.3% (95% CI: 34.8?62.1) until season end. VE against influenza B declined from 70.7% (95% CI: 51.3?82.4) 44 days after vaccination to 21.4% (95% CI: -57.4?60.8) at season end. To assess if vaccination campaign strategies need revising more evidence on VE by time since vaccination is urgently needed.
Tárgyszavak:	Orvostudományok Egészségtudományok idegen nyelvű folyóiratközlemény külföldi lapban folyóiratcikk
Megjelenés:	Euro surveillance. - 21 : 16 (2016), p. 1-12. -
További szerzők:	Nunes, Baltazar Robertson, Chris Valenciano, Marta Reuss, Annicka Larrauri, Amparo Cohen, Jean Marie Oroszi Beatrix (1970-) (orvos, epidemiológus) Rizzo, Caterina Machado, Ausenda Pitigoi, Daniela Domegan, Lisa Paradowska-Stankiewicz, Iwona Buchholz, Udo Gherasim, Alin Daviaud, Isabelle Horváth Judit Krisztina Bella, Antonino Lupulescu, Emilia O'Donnell, Joan Korczyńska, Monika Moren, Alain I-MOVE case-control study team
Internet cím:	Szerző által megadott URL DOI Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Saját polcon:

001-es BibID:	BIBFORM103350
035-os BibID:	(Scopus)76449094520 (WOS)000272247100007
Első szerző:	Kissling, Esther
Cím:	"I-MOVE" towards monitoring seasonal and pandemic influenza vaccine effectiveness : lessons learnt from a pilot multi-centric case-control study in Europe, 2008-9 / E. Kissling, M. Valenciano, J. M. Falcão, A. Larrauri, K. Widgren, D. Pitigoi, B. Oroszi, B. Nunes, C. Savulescu, A. Mazick, E. Lupulescu, B. Ciancio, A. Moren
Dátum:	2009
ISSN:	1025-496X 1560-7917
Megjegyzések:	Within I-MOVE (European programme to monitor seasonal and pandemic influenza vaccine effectiveness (IVE)) five countries conducted IVE pilot case-control studies in 2008-9. One hundred and sixty sentinel general practitioners (GP) swabbed all elderly consulting for influenza-like illness (ILI). Influenza confirmed cases were compared to influenza negative controls. We conducted a pooled analysis to obtain a summary IVE in the age group of ?65 years. We measured IVE in each study and assessed heterogeneity between studies qualitatively and using the I2 index. We used a one-stage pooled model with study as a fixed effect. We adjusted estimates for age-group, sex, chronic diseases, smoking, functional status, previous influenza vaccinations and previous hospitalisations. The pooled analysis included 138 cases and 189 test-negative controls. There was no statistical heterogeneity (I2=0) between studies but ILI case definition, previous hospitalisations and functional status were slightly different. The adjusted IVE was 59.1% (95% CI: 15.3-80.3%). IVE was 65.4% (95% CI: 15.6-85.8%) in the 65-74, 59.6% (95% CI: -72.6 -90.6%) in the age group of ?75 and 56.4% (95% CI: -0.2-81.3%) for A(H3). Pooled analysis is feasible among European studies. The variables definitions need further standardisation. Larger sample sizes are needed to achieve greater precision for subgroup analysis. For 2009-10, I-MOVE will extend the study to obtain early IVE estimates in groups targeted for pandemic H1N1 influenza vaccination.
Tárgyszavak:	Orvostudományok Egészségtudományok idegen nyelvű folyóiratközlemény külföldi lapban folyóiratcikk
Megjelenés:	Eurosurveillance. - 14 : 44 (2009), p. 29-36. -
További szerzők:	Valenciano, Marta Falcão, J. M. Larrauri, Amparo Widgren, K. Pitigoi, Daniela Oroszi Beatrix (1970-) (orvos, epidemiológus) Nunes, Baltazar Savulescu, Camelia Mazick, A. Lupulescu, Emilia Ciancio, Bruno Moren, Alain
Internet cím:	Szerző által megadott URL Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Saját polcon:

001-es BibID:	BIBFORM129001
035-os BibID:	(scopus)85189160966 (wos)001235580600002
Első szerző:	Laniece Delaunay, Charlotte
Cím:	COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022 / Laniece Delaunay Charlotte, Martínez-Baz Iván, Seve Noémie, Domegan Lisa, Mazagatos Clara, Buda Silke, Meijer Adam, Kislaya Irina, Pascu Catalina, Carnahan AnnaSara, Oroszi Beatrix, Ilic Maja, Maurel Marine, Melo Aryse, Sandonis Martín Virginia, Trobajo-Sanmartín Camino, Enouf Vincent, McKenna Adele, Pérez-Gimeno Gloria, Goerlitz Luise, de Lange Marit, Rodrigues Ana Paula, Lazar Mihaela, Latorre-Margalef Neus, Túri Gergő, Castilla Jesús, Falchi Alessandra, Bennett Charlene, Gallardo Virtudes, Dürrwald Ralf, Eggink Dirk, Guiomar Raquel, Popescu Rodica, Riess Maximilian, Horváth Judit Krisztina, Casado Itziar, García M. del Carmen, Hooiveld Mariëtte, Machado Ausenda, Bacci Sabrina, Kaczmarek Marlena, Kissling Esther, European Primary Care Vaccine Effectiveness Group
Dátum:	2024
ISSN:	1025-496X 1560-7917
Tárgyszavak:	Orvostudományok Egészségtudományok idegen nyelvű folyóiratközlemény külföldi lapban folyóiratcikk COVID-19
Megjelenés:	Eurosurveillance. - 29 : 13 (2024), p. 1-14. -
További szerzők:	Martínez-Baz, Iván Seve, Noémie Domegan, Lisa Mazagatos, Clara Buda, Silke Meijer, Adam Kislaya, Irina Pascu, Catalina Carnahan, AnnaSara Oroszi Beatrix (1970-) (orvos, epidemiológus) Ilic, Maja Maurel, Marine Melo, Aryse Sandonis Martín, Virginia Trobajo-Sanmartín, Camino Enouf, Vincent McKenna, Adele Pérez-Gimeno, Gloria Goerlitz, Luise de Lange, Marit Rodrigues, Ana Paula Lazar, Mihaela Latorre-Margalef, Neus Túri Gergő Castilla, Jesús Falchi, Alessandra Bennett, Charlene Gallardo, Virtudes Dürrwald, Ralf Eggink, Dirk Guiomar, Raquel Popescu, Rodica Riess, Maximilian Horváth Judit Krisztina Casado, Itziar García, M. del Carmen Hooiveld, Mariëtte Machado, Ausenda Bacci, Sabrina Kaczmarek, Marlena Kissling, Esther Kolozsvári László Róbert (1977-) (háziorvos) European Primary Care Vaccine Effectiveness Group
Internet cím:	Szerző által megadott URL DOI Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Saját polcon: